Vixiar Medical develops non-invasive, cost-effective devices and systems for monitoring cardiopulmonary diseases.
Vixiar Medical develops non-invasive, cost-effective devices, and systems for monitoring cardiopulmonary diseases, particularly those with a significant clinical and economic burden. The Company’s first product, Indicor, is a handheld point of care device and digital platform for monitoring worsening heart failure.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 20, 2019 | Series A | $1.50M | 2 | — | — | Detail |
| Feb 20, 2018 | Series Unknown | $1.58M | 1 | — | — | Detail |
| Jul 20, 2017 | Seed | $1.50M | 1 |
TEDCO
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
TEDCO
|
— | Series A |
|
|
— | Series A |
Gaingels
|
— | Series Unknown |